Nephritogenicity of proteoglycans. III. Mechanism of immune deposit formation  by Makino, Hirofumi et al.
Kidney international, Vol. 34 (1988), pp. 209—219
Nephritogenicity of proteoglycans. III. Mechanism of immune
deposit formation
HIR0FuMI MAKINO, BRIGITTE LELONGT, and YASHPAL S. KANWAR
Department of Pathology, Northwestern University Medical School, Chicago, Illinois, USA
Nephritogenicity of proteoglycans. Ill. Mechanism of immune deposit
formation. Administration of antibody, directed against glomerular
basement membrane (GBM) heparan sulfate-proteoglycan, into a
presensitized rat results in the induction of membranous nephropathy
with subepithelial immune-complex deposits. In this investigation, we
examined the mechanisms responsible for the formation of subepithelial
immune-complex deposits in the anti-HS-PG model. In initial experi-
ments, the intravenously administered radioiodinated antibody was
seen exclusively localized in the regions of the glomerular capillary wall
where the subepithelial deposits were observed. To determine their
exclusive localization in the subepithelial space, kinetics of movement
of the intravenously administered antibody was investigated. The
antibody localized in the inner layers of the GBM within a few minutes
after its administration. It equilibrated in the inner and outer layers of
the GBM in a matter of a few hours. Then, after 24 hours, it gradually
disappeared from the inner layers of the GBM and persisted in the outer
layers only. The ready clearance of the antibody from the inner layers
may be related to the differential in the kinetics of lateral intrinsic
plasma fluid currents within the GBM. The persistence of heterologous
antibody exclusively in the outer layers and the availability of host
autologous antibodies probably resulted in the development of immune
complex deposits in the subepithelial space. The glomeruli devoid of
plasma water currents showed no change in the concentration of the
antibody in the inner and outer layers of the GBM or mesangial matrix.
Also, no antibody binding was observed with the plasmalemma of either
the foot processes or visceral epithelia. The data suggest that the
biochemical-biophysical properties of the glomerular capillary wall, in
concert with its intraglomerular hemodynamics, most likely played a
significant role in the development of subepithelial immune-complex
deposits in this model.
Glomerular basement membrane (GBM) is an integral com-
ponent of renal mammalian vasculature that restricts the trans-
capillary passage of macromolecules and thus regulates the
formation of an ultrafiltrate from blood [1—5]. It is lined inside
by the attenuated cytoplasm of fenestrated endothelium and
outside by interdigitating epithelial foot processes with inter-
vening slit diaphragms. During the formation of ultrafiltrate, the
plasma water, along with proteins, traverses through the endo-
thelial fenestrae, GBM and slit diaphragms, and reaches the
urinary space. In doing so, the GBM is constantly exposed to
the macromolecules in circulation, including antibodies and
immune complexes. These complexes are observed circulating
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in the blood in many forms of glomerulonephritis [6]. They
localize and form immune complex deposits in various regions
of the renal glomerulus. In a variety of these nephritides, such
as, idiopathic-membranous, post-streptococcal, lupus, and
Heymann, the immune complex deposits are seen localized in
the outer or subepithelial aspect of the GBM [7—10]. In view of
the fact that all the layers of the GBM come in contact with the
immune complexes, the mechanisms for the peculiar selective
formation of immune deposits in the subepithelial space are
poorly understood. It may be that the immune complexes or
antibodies, initially localized within the basement membrane,
clear with varying rates due to the differential in the kinetics of
sweeping plasma water currents in the various layers of the
GBM. Given the possibility that the clearance rate may be
lower in the outer layer of the GBM, it would favor the
retention of antibodies or immune complexes for a prolonged
period with the formation of deposits in the subepithelial space
ultimately. These considerations led us to investigate the move-
ment of antibodies in various layers of the GBM and the
mechanisms involved in the formation of the subepithelial
immune-complex deposits. The model utilized for these studies
is described in the accompanying paper [11]. In this model, the
formation of extensive subepithelial immune-complex deposits
was observed as a result of administration of rabbit anti-
heparan sulfate-proteoglycan (HS-PG) antibody in animals pre-
viously sensitized with rabbit IgG.
Methods
In vivo localization of radioiodinated antibody during various
stages of immune complex nephritis
Twenty rats were preimmunized with normal rabbit IgG as
previously described [11, 12]. Seven days later, they were
intravenously administered with radioiodinated anti-HS-PG an-
tibody (50 mg/l00 g body wt). They were sacrificed in groups of
four at one hour and at 3, 7, 10, and 14 days after the
administration of the radioiodinated antibody. The kidneys
were flushed with normal saline and fixed by perfusion with
Karnovsky's aldehyde fixative. One-mm3 cortical pieces were
made and processed for electron microscopic autoradiography
[13, 14]. The control preimmunized animals received radioiodi-
nated normal IgG.
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Tracking of the movement of the intravenously administered
anti-HS-PG antibody in various layers of the GBM
Preliminary studies were performed to determine the concen-
tration of aldehyde fixative which would cause minimal loss in
the reactivity of the intravenously administered antibody. Fol-
lowing the administration of the antibody, the kidneys were
perfused with various concentrations (0.001 to 1.0%) of alde-
hyde fixatives. They were then washed with 0.1 M cacodylate
buffer, pH 7.4, and snap-frozen in liquid nitrogen; 4-jim thick
cryostat sections were prepared. The sections were stained
with anti-rabbit IgG conjugated with fluorescein and examined.
Approximately 0.05% glutaraldehyde appeared to be suitable,
since at this concentration minimal loss of reactivity was
observed without any substantial compromise in the morphol-
ogy.
Twenty-eight female Fischer rats, each weighing 50 g, were
intravenously administered with 25 mg of anti-HS-PG antibody
and sacrificed, in batches of four, 5 and 15 minutes, 1 and 6
hours, and 1, 3, and 7 days later. Seven control rats received the
same dose of normal rabbit IgO and were sacrificed at the above
designated intervals. At the time of sacrifice, their kidneys were
fixed by perfusion with 0.05% glutaraldehyde in 0.1 M cacodyl-
ate buffer, pH 7.4, for five minutes. After the aldehyde fixative
was flushed out of the kidney with 0.1 M cacodylate buffer,
1-mm3 renal cortical pieces were made and dehydrated in a
graded series of ethanol. No osmication or uranyl acetate en
bloc staining was carried out since these treatments abolished
the tissue reactivity of the antibody. During dehydration, the
temperature of the tissues was gradually lowered to —20°C. A
stepwise infiltration was carried out with Lowicryl K4 medium
and finally embedded in this low temperature polymeric resin
[15]. A uniform polymerization was carried out under ultravio-
let light at —20°C for 24 hours and then at room temperature for
48 hours. Approximately 60-nm thin sections were picked up on
300-mesh nickel grids. The sections were pretreated with 20 m
Tris-buffered saline (TBS), pH 8.2, containing 0.25% bovine
serum albumin (BSA). They were then incubated with diluted
(1:10) anti-rabbit IgG conjugated with 10 nm or 15 nm colloidal-
gold particles (Janssen Pharmaceutica, Belgium) for four hours
at room temperature. The dilution was made with TBS buffer
containing 0.1% BSA. The grids were then washed with TBS
buffer, stained with lead citrate and uranyl acetate, and exam-
ined by an electron microscope at an accelerating voltage of 80
KY.
Sixty glomerular capillary loops per time interval were pho-
tographed and printed to a final magnification of X 50,000. The
number of gold particles present in the inner and outer layers of
the GBM were enumerated, tabulated, and expressed as per jim
length of the basement membrane. Photographs encompassing
mesangium were also taken and printed to a final magnification
of x 25,000. For comparative particle-density analysis, gold
particles present in the whole width of the GBM and mesangial
matrix were enumerated and tabulated. Then the areas of the
GBM and mesangial matrix were determined by the point-
counting method as previously described [13, 16]. The particle
density was obtained by dividing the total number of gold
particles by total area points. Then the particle densities on the
GBM and mesangial matrices were compared with one another
at various time intervals after the administration of the anti-
body. Finally, a ratio of particle density of the mesangial matrix
to the GBM was calculated.
Tracking of movement of antibody in isolated glomeruli
A few experiments were carried out with isolated glomeruli to
confirm that the movement of intravenously administered anti-
body is related to the intrinsic fluid currents in the GBM, that is,
when ultraffitration is proceeding normally. The animals re-
ceived an intravenous injection of anti-HS-PG antibody (100
mg/l00 g body wt). A relatively higher dose of the antibody was
used to achieve its sufficient concentration in the GBM at
earlier time intervals. Thirty minutes after the administration of
the antibody, the kidneys were perfused with oxygenated
Hank's-l% BSA solution, severed from the blood vessels, and
bisected, and glomeruli were isolated from them [17]. An
aliquot of the isolated glomeruli was immersed in an aldehyde
fixative (0.03% glutaraldehyde and 0.15% paraformaldehyde in
0.1 M buffer, pH 7.4) for 15 minutes. The remaining
glomeruli were suspended in Eagle's minimal essential medium,
supplemented with amino acids, 10 mM HEPES, transferrin (5
p,g/ml), 1% BSA, penicillin (100 U/mi), and streptomycin (100
jig/mi). The pH of the medium was adjusted to 7.4 by addition
of NaHCO3 (0.22 g/l00 ml). The glomeruli were cultured for six
hours in the same medium with constant shaking and oxygen-
ation. The cultures were terminated by addition of the aldehyde
fixative. The aliquots of glomeruli from the time of sacrifice (0
hours) and six hours later were made into pellets in a Beckman
microfuge and processed for immunocytochemistry utilizing
immuno-goid particles as described above. The six-hour time
interval was selected as the terminal point since the glomerular
morphology seems to deteriorate beyond this period under
culture conditions. Twenty-five micrographs, from each time
interval (0 and 6 hours), were photographed and printed to a
final magnification of x 25,000. The immuno-gold particles were
enumerated on the mesangial matrix and GBM of the same
micrograph. The particle density analyses and their ratios
(mesangial matrix/GBM) were calculated as described above.
Finally, mean and standard deviation for each of the parameters
were determined.
Antibody binding studies with isolated glomeruli and GBM
In order to ascertain the reactivity of anti-HS-PG antibody
with visceral epithelial cells, the binding experiments were
carried out with isolated glomeruli and GBMs, separately and in
combination. Three sets of experiments were performed.
First, the antibody binding with isolated glomeruli was inves-
tigated. The glomeruli were isolated from kidneys perfused with
oxygenated Hank's balanced salt solution [17]. The glomeruli
isolated from four kidneys were suspended in Hank's-l% BSA
solution with '251-anti-HS-PG antibody (1 mCi/SO mg/ml) for 10
minutes at 4°C. After incubation, the glomeruli were washed
with Hank's-BSA solution, pelleted, and processed for electron
microscopic autoradiography [13, 14, 16].
In the second set of experiments, the antibody binding with
the GBMs was investigated. The glomeruli were isolated, and
basement membrane fractions were prepared by the detergent
method [18, 19]. The GBMs were then incubated with radio-
iodinated antibody and processed.
In the third set of experiments, the isolated glomeruli and
GBM were mixed and a suspension prepared. After the addition
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Fig. 1. Electron microscopic autoradiograms of glomerular capillary loops (Cap) from presensitized rats that received radioiodinated anti-HS-PG
antibody and were sacrificed 1 hour (A), 7 days (B), and 2 weeks (C) later. A. Initially, the antibody (represented as silver grains) is seen uniformly
distributed on either side of the basement membrane (arrows). B. One week later, the grains (arrows) are seen only in the regions where the
subepithelial immune deposits are observed. The regions devoid of deposits (within brackets) are uniformly thin and are free of radioiodinated
antibody. In grazing sections (panel C), the concentration of the antibody (arrows) seems to be proportionately higher in the regions where there
are more subepithelial deposits. US, urinary space; Ep, epithelium; fp, foot processes; En, endothelium. A: x 25,000; B: x 6,000; C: X 15,000.
of radioiodinated antibody, the glomerular-GBM suspension
was incubated for 10 minutes at 4°C and then washed three
times with Hank's-BSA solution. Finally, a pellet was prepared
by centrifugation and processed for electron microscopic auto-
radiography. The total time required for the preparation of
glomeruli, incubation with the antibody, and immersion in the
glutaraldehyde fixative was estimated to be about 30 minutes.
In control experiments, '251-normal rabbit IgG was used in
place of radioiodinated antibody.
Results
Initial observations, which led to the suggestion that HS-PG
may be the site where immune complex deposits form in the
GBM, are detailed in the data presented in the following
section.
In vivo localization of radioiodinated antibody during various
stages of immune complex nephritis
The radioiodinated antibody was seen localized to the GBM
within a few minutes after its administration. The antibody-
corresponding autoradiographic silver grains were seen over
the whole width of the GBM at regular intervals (Fig. 1A). Their
grain-point centers appeared to reside in the inner and outer
layers of the GBMs. This regular pattern of autoradiographic
grains persisted for three to four days; thereafter, their distri-
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bution became somewhat erratic. A week later, when immune
deposits were visualized and irregular thickening of basement
membrane ensued, the grains were seen mainly concentrated in
the altered regions of the GBMs (Fig. 1 B and C). Their concen-
tration seemed to be proportionately higher in the areas of the
GBM having more of the immune deposits (Fig. IB). Moreover,
the point-center of the grains appeared to correspond with the
center of the electron-dense deposits, thus suggesting a topo-
logical superimposition of the radioiodinated anti-HS-PG anti-
body over the immune complex deposits. The regions of the
GBM devoid of deposits were sparsely studded with the auto-
radiographic grains. Further affirmation that the HS-PG site
may serve as the core-nidus for the formation of an immune
complex deposit was obtained in the grazing sections of the
capillary loops. In these sections, the autoradiographic grains
populated mainly in the outer layers of the GBM where the
subepithelial deposits were heavily concentrated (Fig. lC). The
inner layers of the GBM, which were devoid of immune
deposits, did not contain any autoradiographic grains. This
meant that the immune deposits evolved only in the regions
where there is a persistent residence of the intravenously
administered antibody, that is, in the outer layers of the GBM.
These data indicated that there may be a differential in clear-
ance/persistence/residence of the intravenously administered
antibody in various layers of the GBM. The anticipated differ-
ences in the clearance rates of the antibody, localized in the
inner and outer layers of the GBM, are elucidated in the next set
of experiments.
Tracking of the movement of the intravenously administered
anti-HS-PG antibody in various layers of the GBM by
immunoelectron microscopy
The tissues processed for immuno-electron microscopy were
prefixed by a brief exposure to 0.05% glutaraldehyde. At this
concentration of aldehyde, no appreciable loss of the antibody
reactivity was noted. A reassurable linear pattern of immuno-
fluorescence of the GBM was observed upon staining with
anti-HS-PG antibody.
After the administration of IgG fraction of rabbit anti-HS-PG,
the antibody was seen exclusively localized in the GBM. The
antibody was visualized in the GBMs with the use of immuno-
gold particles. No reactivity towards the immuno-gold particles
was observed either on non-glomerular basement membranes
or cell surfaces, indicating an absence of antibody in these
structures. Similarly, no reactivity was observed in tissues from
animals injected with normal rabbit IgG. At early time intervals
(5 and 15 mm), the particles were seen mainly in the inner layer
of the GBM (Fig. 2 A and B). No immunoreactivity was seen in
the mesangium (Fig. 3A). With passage of time (1 and 6 hrs), an
increase in the number of particles in the GBM was noted. They
were seen with almost the same frequency on either sides of the
basement membrane (Fig. 2 C and D). A few particles were
seen in the mesangium at these intervals. In later time points (1,
3, and 7 days), a gradual decrease in the number of particles was
observed (Fig. 2 E and F). The observed decrease was much
steeper for the inner layers of the GBM. On day 7, the inner
layer was virtually free of reactivity towards the immuno-gold
particles (Fig. 2F), and they were exclusively seen in the outer
layer or subepithelial region of the GBM. The mesangium had a
Fig. 2. Electron micrographs of glomerular capillary loops (Cap) ob-
tained from rats sacrificed 5 ,njnutes (A) and 15 minutes (B), 1 hour (C)
and 6 hours (D), I day (E) and 7 days (F) after the administration of the
antibody. The thin sections were prepared on nickel grids and stained with
anti-rabbit IgG conjugated to colloidal gold. The antibody is visualized as
electron-dense gold particles (arrows). At earlier time prints (panels A and
B), the antibody (arrows) is seen mainly in the inner layers of the
glomerular basement membrane (GBM). After I and 6 hours (panels C and
D), the antibody is seen equally distributed on both sides of the GBM. At
later time points, that is, I and 7 days (panels E and F), the antibody is
mainly seen in the outer layers of the GBM. US, urinary space; Ep,
epithelium; fp, foot processes; En, endothelium. A-F: x 75,000.
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Fig. 4. Graphic representation of the antibody Concentration (repre-
sented by immuno-gold particles per jm length of the GBM) in the
inner and outer layers of the basement membrane at various time
intervals after its administration.
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Fig. 3. Electron micrographs of glomerular mesangium (Me) obtained
from rats sacrificed 15 minutes (A) and 3 days (B) after the adminis-
tration of anti-HS-PG antibody. A. At earlier time point, the antibody
(represented by electron-dense colloidal-gold particles) is not seen in
the mesangium, while it (arrows) is normally present in the GBM of
peripheral capillary loops (Cap). B. At later time point, the concentra-
tion of antibody dramatically rises in the mesangium. US, urinary
space; Ep, epithelium; fp, foot processes; En, endothelium, A and B:
x 15,000.
Time of sacrifice
Fig. 5. Graphic representation of the ratio of the antibody (represented
by the immuno-gold particles) in the mesangial matrix (MM) and GBM
of the glomerulus at various time intervals after its administration.
Symbols are: (I) externa; (•) interna.
Tracking of movement of the antibody in isolated glomeruli
progressive increase in the concentration of the antibody, as
evidenced by accentuated reactivity towards immuno-gold par-
ticles (Fig. 3B). Figure 4, prepared after enumeration and
tabulation of the immuno-gold particles, reinforced the qualita-
tive assessment of the concentration of antibody present at
various time intervals in different layers of the GBM. The
comparative particle-density analysis revealed a very low me-
sangial matrix/GBM ratio initially, and it gradually rose to unity
by 12 hours (Fig. 5). The ratio remained at unity for the next
seven days. This indicated that the mesangial matrix gets
saturated with the antibody molecules very early, that is, by 12
hours, and remains saturated for the rest of the investigatory
In these experiments, the movement of the intravenously
administered antibody was investigated in the absence of intra-
glomerular hemodynamics. Thirty minutes after the administra-
tion of the antibody (designated as 0-hour time interval), most
of the immuno-gold particles were seen in the GBM, with very
few in the mesangial matrix (Fig. 6A). The respective particle
densities in the mesangial matrix and GBM were 0.46 0.05
and 3.41 0.04; their ratio (mesangial matrix/GBM) was 0.140
0.024. After six hours of culture, the number of particles in
the GBM and mesangial matrix appeared to be the same as seen
at the 0-hour time interval. No increase in the mesangial matrix
or decrease in the GBM was observed (Fig. 6B). Quantitatively,
the respective particle densities for the mesangial matrix and
6hr lday3day 7day
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period. An occasional immuno-gold particle was observed over
the lysosomes of the mesangial cell.
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Fig. 6. Electron mierographs of isolated glomeruli obtained from rat sacrfficed 30 minutes after the administration of anti-HS-PG antibody (A),
and further in vitro culture for 6 hours (B). The thin sections were prepared and reacted with anti-rabbit igG conjugated to colloidal gold. No
significant change in the concentration of the antibody (represented by electron-dense gold particles) is seen, either in the GBM or mesangial matrix
(MM), during the 6 hours of the incubation period. US, urinary space; Ep, epithelium; fp, foot processes; En, endothelium; Me, mesangium; Cap,
capillary loop. A: x 40,000; B: x 30,000.
GEM were 0.49 0.06 and 3.33 0.39; their ratio was 0.146 From the above experiments, it appears that the mechanisms
0.06. This suggested that no significant movement of the ligand involved in the formation of subepithelial immune-complex
occurs in the extracellular matrices when the kidney is devoid deposits may be regional to the GEM due to its peculiar
of its intraglomerular hemodynamics, that is, the redistribution macromolecular composition. However, in recent years, Dr.
of the ligand ceases completely in the absence of ultraffitration. Andres and his associates have proposed another hypothesis in
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Fig. 7. Electron microscopic autoradiograms of isolated glomeruli (A) and GBMs (B) incubated with radioiodinated anti-HS-PG antibody. A. The
antibody is not seen binding to the visceral epithelium (Ep), and only occasional background grains are observed, B. The antibody (represented
by silver grains and indicated by arrows) is seen bound to the isolated GBM loops. US, urinary space; fp, foot processes; En, endothelium; Me,
mesangium; MM, mesangial matrix; Cap, capillary loop. A: x 6,000; B: x 5,000.
the formation of subepithelial deposits utilizing the model of
Heymann nephritis [20, 21]. According to their hypothesis, the
antibodies bind to the podocytes, cause redistribution and
aggregation of antigen-antibody complexes at the visceral epi-
thelial cell surface, and then shed into the subepithelial regions
where the immune complex deposits are formed ultimately.
Here, the key issue pertains to the fact that the antibody must
bind to the visceral epithelial cells of the glomerulus in the
initial events of Heymann nephritis. To address this issue in our
model, the next series of antibody binding experiments were
performed, and their results are detailed below.
Antibody binding studies with isolated glomeruli and GBMs
By autoradiography, antibody was not seen bound to the
visceral epithelial cells of the isolated glomeruli. Only the
decapsulated glomeruli were examined. A very few background
grains were visualized over the entire regions of the glomerulus
(Fig. 7A). In contrast, a large number of autoradiographic
grains was observed over the isolated GBMs (Fig. 7B), indicat-
ing the binding of radioiodinated antibody to the basement
membrane loops. The background grains in the GBM prepara-
tions were also extremely low. To further confirm these observa-
tions, combined experiments were performed in which GBMs
and isolated glomerular fractions were mixed together and then
incubated with the radioiodinated anti-HS-PG antibody. The
electron microscopic autoradiograms of Figure 8 A and B
reinforced the fact that the anti-HS-PG antibodies do not bind
to the glomerular visceral epithelium and that their binding
characteristics are exclusively limited to the GBMs. In these
micrographs (Fig. 8 A and B), one can readily visualize the
binding of the antibody to the GBM, while the adjacent epithe-
hum or its foot processes are devoid of autoradiographic grains.
Discussion
In this investigation, we have provided the data which
indicate that the intravenously administered anti-HS-PG anti-
body binds on either side of the basement membrane initially;
with progression of time, it is seen only in the outer layers of the
GBM, and, ultimately, the immune deposits are formed in the
subepithelial regions where the heterologous antibody remains
persistently localized. These data suggest that there may be a
differential in the clearance of ligands bound in the inner and
outer layers of the GBM, with a lag in the latter. Under
permissive conditions, that is, availability of antigen:antibody
complexation, the subepithelial deposits are formed at the site
of trapped higands.
There are several factors which influence the formation and
deposition of immune complex deposits in various regions of
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Fig. 8. Electron microscopic autoradiograms of suspension of isolated glomeruli and GBMs incubated with radioiodinated anti-HS-PG antibody.
Most of the antibody (represented by silver grains and indicated by arrows) is seen bound to the GBM loops. Minimal antibody binding to the
epithelium (Ep) and foot processes (fp) is observed. US, urinary space; En, endothelium; Cap, capillary ioops. A: x 30,000; B: X 25,000.
the glomerulus, that is, mesangium, subendothelium, and sub-
epithelium, and these have been the subject of several recent
reviews [9, 10, 2 1—25]. These factors include the size and charge
of the antigen, the antibody, and the immune complex; valence
of the antigen, the affinity of the antibody, the antigen: antibody
ratio, and diffusion coefficient of the complex; and, finally, the
intraglomerular hemodynamics, the microanatomy, and the
macromolecular composition of the glomerulus. Taking all
these factors into consideration, there are two general, funda-
mental mechanisms which have evolved in the last decade to
account for the formation of immune deposits in the glomerular
capillary wall. First, the traditional concept indicates that the
immune complexes are formed in "circulation" and subse-
quently are trapped in the basement membrane, forming elec-
tron-dense deposits in due course of time [6, 26]. The second, a
rather challenging notion with minor variations from model to
model, marshals the idea that the antigen:antibody complexes
are formed "locally" or in situ in the capillary wall [9]. The
basic idea for the latter mechanism hinges on the intriguing
biochemical/biophysical properties of the glomerular capillary
wall, discovered during the middle and late 70's [18, 19, 27—29].
The mechanism of in situ immune-complex formation has
been investigated mainly in Heymann nephritis, the model of
membranous nephropathy in man. In this model, the immune
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deposits are seen in the subepithelial region of the glomerulus
after two to three weeks of active immunization of the animal
with proximal brush border fraction (Fx1A) or its well-charac-
terized purified subfraction, which is gp 330 [30]. Almost similar
lesions can be reproduced by infusion or perfusion of antibodies
directed against Fx1A or its subfraction gp 330 [31, 321,
suggesting that there are certain fixed glomerular antigens with
which the corresponding antibodies can interact, and these
antigenic sites may very well serve as the nidus for the for-
mation of immune complex deposits ultimately. This concept
was strengthened by the experiments carried out with planted
non-renal and non-glomerular anionic and cationic antigens [9].
In this regard, the notion of ionic interactions of antigens,
antibodies, and immune complexes with the GBM was largely
advanced by Gallo et a! [22, 33, 34] and followed by Border and
his colleagues [24, 35]. In these experiments, the evidence was
obtained that the anionic groups of the GBM, enriched with
HS-PG, were the pivotal sites for the formation/deposition of
immune deposits. Conceivably, in this scenario, the immune
complexes are trapped within the GBM by electrostatic inter-
actions or by stereo-specific intercalation between the protein-
polysaccharide residues, that is, HS-PG. These stereo-specific
and electrostatic interactions are quite captivating; neverthe-
less, their role in the formation of immune complex deposits
remains to be exemplified in a given glomerular disease in man.
Also, the role of these exogenous cationic ligands [35—3 7] in the
formation of in situ immune-complex is solely dependent upon
the electrostatic interactions—the interactions in which other
determinants of immune complex formation, that is, van der
Waals forces, are excluded. Moreover, the cationic ligands
(antigens or antibodies), like other non-immune-complex hg-
ands, may cause structural "damage" to the GBM, thus induc-
ing conformational changes within its macromolecular complex
which most likely would lead to spurious localization and
formation of in situ complexes. Thus, the data available in the
literature pertaining to these cationic ligands may be somewhat
difficult to interpret and address with respect to the immuno-
biology in authentic immune-complex nephritis models. On the
other hand, the planted antigen-induced glomerular disease,
that is, Con A:anti-Con A [38], may have some substantive
value in certain immune-complex nephritides in view of the
ubiquitous occurrence of these lectins in the environment to
which one is constantly exposed. In the present model, the role
of ionic interactions is unlikely since the isoelectric point (p1) of
the IgG fraction of rabbit anti-HS-PG turned out to be anionic,
that is, between 5.5 and 5.8 (unpublished results). In any event,
the HS-PG, like certain fractions of Heymann antigen, is an
integral constituent of the capillary wall, although residing at a
different location, but administration of anti-HS-PG induces
identical subepithelial lesions to those seen in Heymann mem-
branous nephropathy. The lesions may be identical; however,
the mechanisms in these two models appear to be entirely
dissimilar.
The mechanism of selective subepithelial immune-complex
deposit formation has been well elucidated by Andres and his
colleagues [20, 21]. According to their hypothesis, intrave-
nously administered anti-gp 330 binds to the visceral epitheli-
urn, the cell surfaces of which are presumably enriched with gp
330. It is followed by a series of events which includes a firm
complexation of antigen : antibody, clustering of the complex,
patching, and its shedding into the subepithelial space with the
formation of immune deposits ultimately. The key to the whole
cascade of events appears to be the homology between gp 330,
a subfraction of Fx1A, and the cell surface-associated glyco-
proteins of the visceral epithelium. In doing so, the interaction
of anti-gp 330 and the epithelial membrane of the foot processes
apposed to the GB M is conceivable, and the formation of an
immune deposit locally is plausible. This hypothesis is quite
attractive, but may be exclusive to Heymann nephritis and not
applicable to other models of membranous nephropathy. In the
anti-HS-PG model, it is unlikely that this sequence of events
occurred in view of the data obtained in this investigation. The
fact that the binding of anti-HS-PG antibody was exclusive to
the GBM, and none with the visceral epithelium, suggests that
there may be some other mechanism which may be operational
in the pathogenesis of subepithelial deposits in this model. The
conceivable sequence of events that one could construct would
be as follows: At the outset, the heterologous antibody binds to
the larnina rara interna (LRI) and externa (LRE) of the GBM,
the regions enriched with HS-PG. The anti-HS-PG antibody is
gradually cleared from the LRI by the lateral sweeping plasma
water currents causing its dislodgment into the mesangium. The
antibody localized in the LRE is not removed readily, which
may be due to a decreased shear force in the plasma water
currents in this particular region of the GBM. Thus, the
antibody in the LRE has a prolonged residence or persistence.
The fact that the animal at this given period is in a hyperimmune
state, due to presensitization, would lead to a ready production
of autologous antibodies. These antibodies would bind to the
planted heterologous antibodies, and the formation of electron-
dense immune deposits in the subepithelial space ensues.
Alternatively, the antigen: antibody complexes (anti-HS-PG:
anti-anti-HS-PG) could have formed in circulation, gained ac-
cess to the LRI, dissociated in the GBM, reaggregated in the
LRE, and formed a deposit in the subepithelial space. This
latter possibility is unlikely in view of the fact that the heterol-
ogous antibody disappears readily from the blood before the
animal achieves sufficient titer of the autologous antibody to
form immune complexes in circulation. The third possibility
that one could conceive would be that the heterologous anti-
body or immune complexes in LRI were readily removed by the
mononuclear phagocytes and the ones in the LRE were inac-
cessible to them. One may argue against this idea by the fact
that PMNs or monocytes were seen in sufficient numbers "in
opposition" with the GBM very transiently, while the heterol-
ogous antibody was seen in the LRI for a much longer duration.
Also during this period, no decrease in the concentration of the
antibody in LRE and LRI of isolated glomeruhi was observed,
which would suggest a less significant role of monocytes or
mesangial cells in clearing up the higands from LRI and an
important role of lateral intrinsic fluid currents traversing within
the GBM. Thus, the mechanism that one can conceptualize in
our model would pertain to the persistent residence of the
heterologous antibody in LRE, indirectly related to the differ-
ential in the kinetics of plasma currents in various layers of the
basement membrane (Fig. 9) which lead to the evolution of
subepithelial deposits. Further evidence for the hypothesis of
the differential clearance of ligands from various layers of the
GBM has also been elucidated in the past by other investigators
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FIg. 9. Schematic drawing illustrative of kinetics of plasma water currents in various layers of the glomerular basement membrane (GBM).
Normally, the blood/plasma water currents collide vertically with the glomerular capillary wall and are deflected, resulting in the generation of
lateral secondary currents. The kinetics of these lateral plasma water currents are strongest at the level of lamina rara interna (LRI, represented
by long thick arrows), modest in the lamina densa (LD, represented by medium-sized arrows), and weakest in lamina rara externa (LRE,
represented by interrupted thin arrows). The data included in this investigation indicate the possible existence of such currents within the GBM.
The currents being strongest in the inner layers, that is, LRI, wash away the immune complexes by virtue of the shear forces and thus the formation
of local immune deposits is prevented. While the immune complexes persist in the outer layers, that is, LRE, for a considerable longer period
because the shear forces are weak, and this most likely results, under appropriate conditions, in the evolution of subepithelial immune-complex
deposits.
[36] with the use of exogenous cationic macromolecules, such
as, cationic ferritin.
In conclusion, we have presented another hypothesis which
may be relevant in the pathogenesis of subepithelial immune
deposits in membranous nephropathy.
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